Sheppard Mullin Richter & Hampton LLP
Imidazopyridines Syk inhibitors
Certain imidazopyridines and pharmaceutical compositions thereof are provided herein. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provided. Also provided are methods for determining the presence or absence of Syk kinase in a sample.
Gilead Connecticut, Inc.
C A A A A A A A A C A A C A A A A A C A A A A C A A A A A A A
C07D A61P A61K A61K A61K A61P A61K A61P A61P C07D A61K A61K C12Q A61K A61P A61K A61P A61P C07D A61P A61K A61P A61K C07D A61K A61P A61P A61P A61K A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Peter A. Seung H. Aaron C. Kevin S. Zhongdong Scott A. Jianjun Jeffrey E.
Blomgren Lee Schmitt Currie Zhao Mitchell Xu Kropf